Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析

【英語タイトル】Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(SWOT20MY4614)・商品コード:SWOT20MY4614
・発行会社(調査会社):MarketLine
・発行日:2020年2月
・ページ数:43
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Achillion Pharmaceuticals (Achillion or ‘the company’) is an American biopharmaceutical company that develops, discovers, and markets drugs for the treating infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. Its lead drug candidate includes ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. The company is developing ACH-5228, a factor D inhibitor that is in Phase I clinical trial; ACH-5548, a factor D inhibitor; and other factor D inhibitors. It has license agreements with GCA Therapeutics, Ltd and Ora, Inc., as well as a collaboration arrangement with Janssen Pharmaceuticals Inc. The company operates in the US. The company is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Achillion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Achillion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Achillion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Achillion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Achillion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Achillion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Achillion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Achillion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Achillion Pharmaceuticals, Inc.: Company Overview
Achillion Pharmaceuticals, Inc.: Overview and Key Facts
Achillion Pharmaceuticals, Inc.: Overview
Achillion Pharmaceuticals, Inc.: Key Facts
Achillion Pharmaceuticals, Inc.: Key Employees
Achillion Pharmaceuticals, Inc.: Key Employee Biographies
Achillion Pharmaceuticals, Inc.: Major Products and Services
Achillion Pharmaceuticals, Inc.: Company History
Achillion Pharmaceuticals, Inc.: Management Statement
Achillion Pharmaceuticals, Inc.: Key Competitors
Achillion Pharmaceuticals, Inc.: Company Analysis
Achillion Pharmaceuticals, Inc.: Business Description
Achillion Pharmaceuticals, Inc.: SWOT Analysis
Achillion Pharmaceuticals, Inc.: SWOT Overview
Achillion Pharmaceuticals, Inc.: Strengths
Achillion Pharmaceuticals, Inc.: Weaknesses
Achillion Pharmaceuticals, Inc.: Opportunities
Achillion Pharmaceuticals, Inc.: Threats
Achillion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Achillion Pharmaceuticals, Inc.: Financial Deals Overview
Achillion Pharmaceuticals, Inc.: Targets and Partners
Achillion Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*
Achillion Pharmaceuticals, Inc.: Advisors
Achillion Pharmaceuticals, Inc.: Top Legal Advisors
Achillion Pharmaceuticals, Inc.: Top Financial Advisors
Achillion Pharmaceuticals, Inc.: Capital Raising
Achillion Pharmaceuticals, Inc.: Private Equity and Ownership
Achillion Pharmaceuticals, Inc.: Recent Developments
Achillion Pharmaceuticals, Inc.: News and Events Summary
Achillion Pharmaceuticals, Inc.: Business Expansion
Achillion Pharmaceuticals, Inc.: Corporate Governance
Achillion Pharmaceuticals, Inc.: Financial Performance
Achillion Pharmaceuticals, Inc.: Market Developments
Achillion Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Achillion Pharmaceuticals, Inc.: Key Facts
Table 2: Achillion Pharmaceuticals, Inc.: Key Employees
Table 3: Achillion Pharmaceuticals, Inc.: Company History
Table 4: Achillion Pharmaceuticals, Inc.: Key Competitors
Table 5: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Achillion Pharmaceuticals, Inc.: Targets and Partners
Table 8: Achillion Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 9: Achillion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Achillion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Achillion Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: Achillion Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 14: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 15: Achillion Pharmaceuticals, Inc.: News and Events Summary
Table 16: Achillion Pharmaceuticals, Inc.: Business Expansion
Table 17: Achillion Pharmaceuticals, Inc.: Corporate Governance
Table 18: Achillion Pharmaceuticals, Inc.: Financial Performance
Table 19: Achillion Pharmaceuticals, Inc.: Market Developments
Table 20: Achillion Pharmaceuticals, Inc.: Research & Development

★調査レポート[Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析] (コード:SWOT20MY4614)販売に関する免責事項を必ずご確認ください。
★調査レポート[Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆